Endothelial cells lining transjugular intrahepatic portasystemic shunts originate in hepatic sinusoids: Implications for pseudointimal hyperplasia

Hepatology

Volumn 29, Issue 3, 1999, Pages 710-718

  Sanyal, Arun J ^a   Mirshahi, Faridoddin ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; CD14 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; COLLAGEN TYPE 4; VON WILLEBRAND FACTOR;

ARTERY INTIMA PROLIFERATION; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SEPARATION; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER SINUSOID; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VASCULAR ENDOTHELIUM;

EID: 0033019265     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290323     Document Type: Article

References (12)

1. Sanyal AJ, Freedman AM, Luketic VA, Purdura PP, Shiffman ML, DeMeo J, Cole PE, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112:889-898.
2. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP, Shiffman ML, Tisnado J, Cole PE. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 1996;111:138-146.
3. Stanley AJ, Jalan R, Forrest EH, Redhead DN, Hayes PC. Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients. Gut 1996;39:479-485.
4. LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan RK Jr., Ascher NL, Roberts JP, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995;108:1143-1151.
5. LaBerge JM, Ferrell LD, Ring EJ, Gordon RL. Histopathologic study of stenotic and occluded transjugular intrahepatic portasystemic shunts. J Vase Interv Radiol 1993;4:779-786.
6. Saxon RR, Mendel-Hartvig J, Corless CL, Rabkin J, Uchida BT, Nishimine K, Keller FS. Bile duct injury as a major cause of stenosis and occlusion in transjugular intrahepatic portosystemic shunts: comparative histopathologic analysis in humans and swine. J Vase Interv Radiol 1996;7:487-497.
7. Ducoin H, El-Khoury J, Rousseau H, Barange K, Peron JM, Pierragi MT, Rumeau JL, et al. Histopathologic analysis of transjugular intrahepatic portasystemic shunts. HEPATOLOGY 1997;25:1064-1069.
8. Sanyal AJ, Contos MJ, Willey A, Zhou Y, Yager D, Graham ME Development of pseudointimal hyperplasia after transjugular intrahepatic portasystemic shunts (TIPS): isolation and phenotypic and functional characterization of mesenchymal cells. HEPATOLOGY 1998;28:22-32.
9. Davies MG, Hagen PO. Pathobiology of intimai hyperplasia. Br J Surg 1994;81:1254-1269.
10. Davies MG, Hagen PO. Structural and functional consequences of bypass grafting with autologous vein. Cryobiology 1994;31:63-70.
11. Scott-Burden T, Vanhoutte PM. Regulation of smooth muscle cell growth by endothelium-derived factors. Tex Heart Inst J 1994;21:91-97.
12. Jackson CJ, Garbett PK, Nissen B, Schreiber L. Binding of human endothelium to ulex europeus I-coated Dynabeads: application to the isolation of microvascular endothelium. J Cell Science 1990;96:257-262.